Home Forums Melanoma Diagnosis: Stage IV Merck Vs. Bristol In PD-1 Cancer Drug Race Reply To: Merck Vs. Bristol In PD-1 Cancer Drug Race

#63255
MathewR
Participant

Lesli, I don’t know the answers to your questions, but I’ll speculate that for business reasons, BMS will go for approval for Nivo to be used in combination with ipi. Why orphan your existing blockbuster (ipi)?